NCT06786429Not yet recruitingPhase 4
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers Among Women of Childbearing Age, and Young Adults in Zimbabwe in the Context of Mental Health: a Multimodal, Multifaceted Approach.
Source: ClinicalTrials.gov · Last updated 30 Jul 2026
Brief summary (registry, in English)
Aim: The main goal of this quantitative epidemiological observational study is to determine the prevalence of Human Papilloma Virus (HPV) infection and Hepatitis B (Hep B) immunity amongst women of childbearing age. attending clinics at Mtshabezi Mission and Matobo clinic respectively, and assessing behavioral risk factors of high school students at these catchment areas that can put them at risk for developing cancer of the cervix and liver. Question: Can screening for cancer, vaccination against Hep B and HPV, and cognitive behavior intervention help in preventing related cancers amongst these groups of participants?
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 2140 (estimated)
- First submitted
- 13 Jan 2025
- Start date
- 30 Jan 2027
- Primary completion date
- 15 Dec 2032
- Lead sponsor
- Eunice Dube
- NCT number
- NCT06786429
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 2140
- From 30 Jan 2027 to the primary completion date, 15 Dec 2032
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any potential participant who is excluded by a doctor or midwife for a known contraindicating medical condition that can lead to potential harm to the participant or staff.
- Any potential participant who is unable to understand and respond to the questions being asked.
Age
- children below the age of thirteen who are not enrolled in high schools and are not seeking prenatal, post-partum, and family planning services at these selected health facilities during the project period.
Other
- males who are not enrolled in these participating High Schools.
- Any eligible potential participant without a valid consent.
Who the study is looking for
- For the High school students' group:
- All students aged 13 years and older, enrolled at the selected Mtshabezi and Matopo High Schools in the Gwanda and Matobo Rural Districts during the five years of the project, are eligible to participate in the study.
- Ability to understand and respond to questions on the Youth Risk Behavior Survey questionnaire and PHQ-9 scale.
- Relevant history of HPV vaccine administration. Ability to obtain parental/guardian consent for participation.
- \- For the women's group: All women and young female adults, thirteen to fifty years old, and requesting health services for prenatal, post-partum, family planning, and other care during the five-year project period are eligible to participate.
- Can understand and respond to the PHQ-9 and Edinburgh Postnatal Depression scales.
- Must have a valid consent for participation in the study.
Age in the registry: 13 years to 50 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.